EP 1781302 A1 20070509 - NEW USE
Title (en)
NEW USE
Title (de)
NEUE VERWENDUNG
Title (fr)
NOUVELLE UTILISATION
Publication
Application
Priority
- SE 2005001184 W 20050726
- US 59161504 P 20040728
- SE 0401943 A 20040728
Abstract (en)
[origin: WO2006011849A1] The present invention relates to the use of a vitamin D compound active in up-regulating the expression and production of hCAP18 in humans for the manufacture of a medicament for treatment of conditions deficient in or benefiting from LL-37. The vitamin D active compound can be used as a medicament for treatment of injured tissues, chronic ulcers, burn wounds, skin infections and atopic dermatitis and for improving the microvasculature. UVB irradiation can also be used to up-regulate hCAP18.
IPC 8 full level
A61K 31/592 (2006.01); A61K 31/593 (2006.01); A61P 17/02 (2006.01); A61P 31/04 (2006.01)
CPC (source: EP)
A61K 31/592 (2013.01); A61K 31/593 (2013.01); A61P 17/02 (2017.12); A61P 31/04 (2017.12)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006011849 A1 20060202; AU 2005267629 A1 20060202; CA 2581693 A1 20060202; EP 1781302 A1 20070509; EP 1781302 A4 20100217
DOCDB simple family (application)
SE 2005001184 W 20050726; AU 2005267629 A 20050726; CA 2581693 A 20050726; EP 05766728 A 20050726